Opiant Pharmaceuticals Inc (OPNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | OPNT | PRLD | RLMD | ||
Company | Opiant Pharmaceuticals Inc | Prelude Therapeutics Inc | Relmada Therapeutics Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 20.88 | 2.55 | 3.48 | ||
High | 21.00 | 2.67 | 3.63 | ||
Low | 20.50 | 2.45 | 3.44 | ||
Last | 20.65 | 2.55 | 3.46 | ||
Change | -0.12 | unch | -0.04 | ||
% Change | -0.58% | -0.20% | -1.14% | ||
Volume | 562,700 | 260,514 | 229,962 | ||
20-Day Average Volume | 83,820 | 480,610 | 300,619 | ||
Previous Close | 20.77 | 2.55 | 3.50 | ||
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 20.78 | 4.38 | 2.92 | ||
20-Day Raw Stochastic | 44.71% | 4.23% | 72.50% | ||
20-Day Relative Strength | 55.75% | 34.33% | 58.44% | ||
Weighted Alpha | -33.30 | -12.01 | +1.70 | ||
Today's Opinion | 88% Buy | 24% Sell | 40% Sell | ||
Previous Opinion | 100% Buy | 8% Sell | 40% Sell | ||
Last Month's Opinion | 72% Buy | 88% Buy | 100% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | -1.05% since 02/22/23 | -7.94% since 09/13/24 | +12.62% since 09/13/24 | ||
Low | 20.50 on 03/01/23 | 2.40 on 09/17/24 | 3.00 on 09/16/24 | ||
High | 21.04 on 02/24/23 | 2.84 on 09/16/24 | 3.79 on 09/18/24 | ||
1-Month | |||||
%Chg | +3.10% since 02/01/23 | -51.70% since 08/20/24 | +28.89% since 08/20/24 | ||
Low | 20.00 on 02/02/23 | 2.40 on 09/17/24 | 2.32 on 09/06/24 | ||
High | 21.46 on 02/16/23 | 5.95 on 08/23/24 | 3.92 on 09/12/24 | ||
3-Month | |||||
%Chg | +2.28% since 12/01/22 | -31.17% since 06/20/24 | +14.47% since 06/20/24 | ||
Low | 19.96 on 01/26/23 | 2.40 on 09/17/24 | 1.88 on 08/12/24 | ||
High | 21.46 on 02/16/23 | 6.80 on 08/14/24 | 4.47 on 07/11/24 | ||
6-Month | |||||
%Chg | +83.72% since 09/01/22 | -47.31% since 03/20/24 | -21.53% since 03/20/24 | ||
Low | 9.12 on 11/07/22 | 2.40 on 09/17/24 | 1.88 on 08/12/24 | ||
High | 21.46 on 02/16/23 | 6.80 on 08/14/24 | 5.13 on 03/25/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 106,641 | 107,301 | 105,609 | ||
Shares Outstanding, K | 5,164 | 42,079 | 30,174 | ||
Annual Sales | 47,790,000 | 0 | 0 | ||
Annual Net Income | 3,010,000 | -121,830,000 | -98,790,000 | ||
Last Quarter Sales | 170,000 | 0 | 0 | ||
Last Quarter Net Income | -9,920,000 | -34,740,000 | -17,770,000 | ||
60-Month Beta | 0.84 | 1.52 | 0.50 | ||
Per-Share Information | |||||
Most Recent Earnings | -1.93 on 11/14/22 | -0.46 on 08/12/24 | -0.59 on 08/07/24 | ||
Latest Earnings Date | 03/21/23 | 11/06/24 | 11/13/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | 09/10/12 | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |